You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
The integration on the Microsoft Azure cloud is helping Kaiser make its vast genomics dataset available to a wider pool of researchers.
The group's CureCloud initiative combines patient health data with sequencing data from its liquid biopsy test to help oncologists select treatments.
The deal expands Illumina's cloud-based data analysis portfolio and gives its customers access to tools to boost assay and operational efficiency.
OnRamp Bio's Rosalind genomic informatics platform will replace Canopy's legacy bioinformatics platform as the CRO expands into the clinical market.
In Phase 2 pilots, four healthcare organizations helped HL7 refine its FHIR Genomics specification but uncovered many remaining hurdles to true interoperability.
The bioinformatics vendor is customizing a multiomics health data platform to help pancreatic cancer researchers pursue new therapeutic targets.
The companies will bundle claims analytics, clinical decision support, provider education, and other pharmacist-driven support for prescribers.
Launched last month as part of the EU's coronavirus action plan, the portal will collect and distribute SARS-CoV-2 sequencing and patient phenotype data.
The agency plans to work with a number of partners to develop codes that will describe tests and results to standardize data collection.
The newly launched EndPandemic National Data Consortium brings together seven life sciences and bioinformatics firms in search of treatments and vaccines.
Novavax has begun a phase III trial of its SARS-CoV-2 vaccine, according to the New York Times.
Vox reports that the Trump Administration may limit student visas for individuals from some countries to two years.
The governor of New York says the state will conduct its own review of any SARS-CoV-2 vaccine, NPR reports.
This week in Science: Neanderthal Y chromosomes replaced by Homo sapiens Y chromosomes, and more.